Leah Lawrence

Patients with acute myeloid leukemia who have undergone autologous stem cell transplantation and survived without disease recurrence for at least 2 years are still at risk for late recurrences.

Higher preoperative levels of serum albumin were significantly associated with greater overall survival among patients undergoing resection of pancreatic adenocarcinoma.

The diabetes drug pioglitazone was associated with an increased risk for bladder cancer among patients with type 2 diabetes, according to the results of a new study.

Researchers have found a link between the duration of fasting at night and the risk for breast cancer recurrence among women with early-stage breast cancer.

Making the decision to die at home rather than in a hospital setting resulted in a similar or longer survival, according to the results of a study.

The FDA has approved two indications of a new formulation of melphalan hydrochloride called Evomela for the treatment of multiple myeloma.

People at high-risk for lung cancer with a clean annual low-dose CT scan had a lower incidence of lung cancer and a lower risk of dying from lung cancer compared with all high-risk participants undergoing screening.

The phase III HYPRO study failed to prove the non-inferiority of using hypofractionated radiotherapy compared with fractionated radiotherapy for late genitourinary and gastrointestinal toxicity in men with intermediate- or high-risk prostate cancer.

The injectable drug APO866, designed to induce apoptosis, did not have efficacy against cutaneous T-cell lymphoma, according to the results of small study.

Women who were treated with chemotherapy for a childhood cancer still had a good chance of becoming pregnant later in life, according to the results of a new analysis.

Undergoing surveillance with PET/CT resulted in similar survival to planned neck dissection in patients with squamous cell carcinoma of the head and neck with nodal disease who have completed chemoradiotherapy.

The combination use of sulindac and erlotinib significantly reduced the number of small intestine, or duodenal, polyps present in patients with familial adenomatous polyposis.

Researchers have identified several characteristics of metastatic papillary thyroid cancer shown on preoperative ultrasound-such as node matting-that are associated with extranodal extension, an important prognostic factor linked with this disease.

Early relapse after stem cell transplant was linked with worse overall survival in multiple myeloma patients who received a novel agent prior to transplant.

The FDA has announced its approval of crizotinib (Xalkori) for the treatment of patients with non–small-cell lung and ROS1 rearrangements.

Results of a new Swedish study have shown that a surgeon needed to perform at least 15 esophagectomies in cancer patients in order to achieve stable survival results in the first months after the operation.

US-born Hispanics are more likely to get hepatocellular carcinoma and to die from chronic liver disease compared with their foreign-born counterparts.

Higher levels of the hormone adiponectin may protect against the development of multiple myeloma in overweight and obese individuals.

Regular use of aspirin has been linked with a small but significant reduction in the risk for overall cancer, and especially gastrointestinal cancers.

The number of moles, or nevi, a patient had was not related to the likelihood that they had melanoma, according to the results of a new study.

Baseline serum levels of the inhibiting inflammatory cytokine interleukin-10 (IL-10) were predictive of prognosis in a group of patients with multiple myeloma.

The combination of TriMixDC-MEL and ipilimumab produced durable tumor responses in patients with pretreated advanced melanoma, according to a phase II study.

The addition of selective internal radiation therapy with yttrium-90 resin microspheres to standard FOLFOX chemotherapy did not improve progression-free survival in patients with metastatic colorectal cancer, but it did significantly delay disease progression in the liver.

Assignment to a dose-dense regimen of paclitaxel given weekly did not prolong progression-free survival compared with paclitaxel given every 3 weeks in a group of patients with ovarian cancer treated with or without bevacizumab.

Although a child’s socioeconomic status did not seem to significantly affect 5-year overall survival ALL, those children who were from high-poverty areas experienced early relapse compared with children who were from low-poverty areas.

Individuals with increased height or body mass index during adolescence showed an increased association with a diagnosis of non-Hodgkin lymphoma.

A pilot program that integrated costs associated with some of the most common cancer treatment protocols with electronic medical records was successful in providing value to both physicians and patients.

Despite similar survival, multiple myeloma patients treated with lenalidomide experienced lower rates of neurologic toxicity than those treated with thalidomide.

Adjuvant high-dose interferon alfa-2b did not improve survival in melanoma patients with single tumor–positive lymph nodes found with sentinel lymph node biopsy.